Carson Wealth (CWM LLC)
JANX icon

Carson Wealth (CWM LLC)’s Janux Therapeutics JANX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.7K Buy
554
+525
+1,810% +$7.2K ﹤0.01% 4880
2025
Q4 		$0 Buy
29
+25
+625% +$588 ﹤0.01% 5501
2025
Q3 		$0 Sell
4
-118
-97% -$2.87K ﹤0.01% 5405
2025
Q2 		$3K Sell
122
-229
-65% -$6.03K ﹤0.01% 4777
2025
Q1 		$9K Buy
351
+336
+2,240% +$12.7K ﹤0.01% 4165
2024
Q4 		$1K Buy
15
+7
+88% +$370 ﹤0.01% 4728
2024
Q3 		$0 Buy
8
+5
+167% +$218 ﹤0.01% 4976
2024
Q2 		$0 Buy
3
+2
+200% +$94 ﹤0.01% 4747
2024
Q1 		$0 Buy
+1
New +$22 ﹤0.01% 4521

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Carson Wealth (CWM LLC)'s JANX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Janux Therapeutics (JANX) stake by 1,810% in Q1 2026, buying an estimated $7.2K and bringing the position to 554 shares worth $7.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4880.

Carson Wealth (CWM LLC) first reported a position in JANX in Q1 2024 and has held it in 9 quarters since. The position peaked at $9K in Q1 2025. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • Carson Wealth (CWM LLC) held 554 shares of Janux Therapeutics worth $7.7K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 525 Janux Therapeutics shares in Q1 2026, an estimated $7.2K.
  • Janux Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4880 holding.
  • Carson Wealth (CWM LLC) first reported a position in Janux Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • Carson Wealth (CWM LLC)'s Janux Therapeutics position peaked at $9K in Q1 2025.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.